Short description
Avadel is a biopharmaceutical company focused on transforming medicines to transform lives.
Description
Avadel Pharmaceuticals plc (Nasdaq:AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and through in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (CNS) / sleep, and hospital markets. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Dublin, Dublin, Ireland, Europe
Founded on
January 1, 1990
Exited on
June 7, 1996
Went public on
June 7, 1996
Stock symbol
AVDL
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Nopepepe, Noaccess, Blurry Noaccess, Nopepepe, Cannot Access, Noaccess
Sign in for full access